HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

IgG Antibodies, SARS-CoV-2 Load, and Prognostic Indicators in Patients with Severe and Mild COVID-19 in Japan.

Abstract
We assessed the association of severity of coronavirus disease 2019 (COVID-19) with acute respiratory syndrome coronavirus 2 (SARS-CoV-2) load, IgG antibody level, and prognostic indicators.Twenty-one patients hospitalized with COVID-19 were classified as having severe or mild disease on the basis of average respiratory rate during hospitalization (severe: ≥22 breaths/min; mild: <22 breaths/min). Viral load in nasopharyngeal samples, blood levels of C-reactive protein (CRP), lymphocytes, and D-dimer on admission and plasma immunoglobulin G (IgG) index on Day 7±2 after symptom onset were compared in relation to disease severity. Seven patients had severe disease and 14 had mild disease. Those with severe disease had a significantly higher IgG index (median: 3.75 vs 0.56, p=0.01) and CRP (median: 8.6 vs 1.0 mg/dL, p<0.001) and D-dimer levels (median: 1.65 vs 0.75 μg/mL; p=0.002) and a significantly lower lymphocyte count (median: 1,176 vs 666 cells/μL, p=0.005) and viral load (median: 8.7×106 vs 2.3×104 copies/mL, p=0.005). Furthermore, time from symptom onset to virus disappearance was significantly longer in severe patients (median: 24 vs 17 days, p=0.03). A high IgG index in the early phase of the disease was associated with severe disease and might serve as a prognostic indicator.
AuthorsKatsuhito Kashiwagi, Tadashi Maeda, Sadako Yoshizawa, Takahiro Sato, Kotaro Aoki, Yoshikazu Ishii, Kazuhiro Tateda
JournalJournal of Nippon Medical School = Nippon Ika Daigaku zasshi (J Nippon Med Sch) Vol. 88 Issue 4 Pg. 380-383 (Sep 01 2021) ISSN: 1347-3409 [Electronic] Japan
PMID33250476 (Publication Type: Journal Article)
Chemical References
  • Antibodies, Viral
  • Biomarkers
  • Immunoglobulin G
Topics
  • Adult
  • Aged
  • Antibodies, Viral (blood)
  • Biomarkers (blood)
  • COVID-19 (blood, diagnosis, therapy, virology)
  • COVID-19 Nucleic Acid Testing
  • COVID-19 Serological Testing
  • Female
  • Hospitalization
  • Host-Pathogen Interactions
  • Humans
  • Immunoglobulin G (blood)
  • Japan
  • Male
  • Middle Aged
  • Oxygen Inhalation Therapy
  • Predictive Value of Tests
  • Prognosis
  • SARS-CoV-2 (genetics, immunology, pathogenicity)
  • Severity of Illness Index
  • Time Factors
  • Viral Load
  • COVID-19 Drug Treatment

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: